279 related articles for article (PubMed ID: 18097027)
1. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors.
Ding JW; Zhou T; Zeng H; Ma L; Verbeek JS; Yin D; Shen J; Chong AS
J Immunol; 2008 Jan; 180(1):261-8. PubMed ID: 18097027
[TBL] [Abstract][Full Text] [Related]
2. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts.
Yin D; Zeng H; Ma L; Shen J; Xu H; Byrne GW; Chong AS
J Immunol; 2004 Jun; 172(12):7235-8. PubMed ID: 15187097
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice.
Baudino L; Nimmerjahn F; Azeredo da Silveira S; Martinez-Soria E; Saito T; Carroll M; Ravetch JV; Verbeek JS; Izui S
J Immunol; 2008 Feb; 180(3):1948-53. PubMed ID: 18209093
[TBL] [Abstract][Full Text] [Related]
4. Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.
Giorgini A; Brown HJ; Lock HR; Nimmerjahn F; Ravetch JV; Verbeek JS; Sacks SH; Robson MG
J Immunol; 2008 Dec; 181(12):8745-52. PubMed ID: 19050295
[TBL] [Abstract][Full Text] [Related]
5. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.
Xu H; Yin D; Naziruddin B; Chen L; Stark A; Wei Y; Lei Y; Shen J; Logan JS; Byrne GW; Chong AS
J Immunol; 2003 Feb; 170(3):1531-9. PubMed ID: 12538718
[TBL] [Abstract][Full Text] [Related]
6. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
[TBL] [Abstract][Full Text] [Related]
7. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.
Azeredo da Silveira S; Kikuchi S; Fossati-Jimack L; Moll T; Saito T; Verbeek JS; Botto M; Walport MJ; Carroll M; Izui S
J Exp Med; 2002 Mar; 195(6):665-72. PubMed ID: 11901193
[TBL] [Abstract][Full Text] [Related]
8. IgG subclasses determine pathways of anaphylaxis in mice.
Beutier H; Gillis CM; Iannascoli B; Godon O; England P; Sibilano R; Reber LL; Galli SJ; Cragg MS; Van Rooijen N; Mancardi DA; Bruhns P; Jönsson F
J Allergy Clin Immunol; 2017 Jan; 139(1):269-280.e7. PubMed ID: 27246523
[TBL] [Abstract][Full Text] [Related]
9. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
Nandakumar KS; Andrén M; Martinsson P; Bajtner E; Hellström S; Holmdahl R; Kleinau S
Eur J Immunol; 2003 Aug; 33(8):2269-77. PubMed ID: 12884302
[TBL] [Abstract][Full Text] [Related]
10. Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies.
Saethre M; Sølvik UØ; Haraldsen G; Fiane AE; Boretti E; Thorsby E; Platt JL; Mollnes TE
Xenotransplantation; 2002 Sep; 9(5):350-8. PubMed ID: 12199866
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice.
Van Snick JL; Coulie P
J Exp Med; 1982 Jan; 155(1):219-30. PubMed ID: 6976413
[TBL] [Abstract][Full Text] [Related]
12. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE
Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo.
Germann T; Bongartz M; Dlugonska H; Hess H; Schmitt E; Kolbe L; Kölsch E; Podlaski FJ; Gately MK; Rüde E
Eur J Immunol; 1995 Mar; 25(3):823-9. PubMed ID: 7705414
[TBL] [Abstract][Full Text] [Related]
14. Rat monoclonal antibodies to mouse IgG1, IgG2a, IgG2b, and IgG3 subclasses, and kappa chain isotypic determinants.
Labit C; Pierres M
Hybridoma; 1984; 3(2):163-9. PubMed ID: 6207100
[TBL] [Abstract][Full Text] [Related]
15. Genetic control of the humoral responses to xenografts. III. Identification of the immunoglobulin V(H) genes responsible for encoding rat immunoglobin G xenoantibodies to hamster heart grafts.
Gochi E; Wu GD; Wakiyama S; Kearns-Jonker M; Swensson J; Cramer DV
Transplantation; 1999 Jul; 68(1):15-24. PubMed ID: 10428261
[TBL] [Abstract][Full Text] [Related]
16. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
[TBL] [Abstract][Full Text] [Related]
17. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.
Lilienthal GM; Rahmöller J; Petry J; Bartsch YC; Leliavski A; Ehlers M
Front Immunol; 2018; 9():958. PubMed ID: 29867943
[TBL] [Abstract][Full Text] [Related]
18. FcgammaRIV: a novel FcR with distinct IgG subclass specificity.
Nimmerjahn F; Bruhns P; Horiuchi K; Ravetch JV
Immunity; 2005 Jul; 23(1):41-51. PubMed ID: 16039578
[TBL] [Abstract][Full Text] [Related]
19. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.
Fossati-Jimack L; Ioan-Facsinay A; Reininger L; Chicheportiche Y; Watanabe N; Saito T; Hofhuis FM; Gessner JE; Schiller C; Schmidt RE; Honjo T; Verbeek JS; Izui S
J Exp Med; 2000 Apr; 191(8):1293-302. PubMed ID: 10770797
[TBL] [Abstract][Full Text] [Related]
20. Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions.
Baudino L; Nimmerjahn F; Shinohara Y; Furukawa J; Petry F; Verbeek JS; Nishimura S; Ravetch JV; Izui S
J Immunol; 2008 Sep; 181(6):4107-12. PubMed ID: 18768867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
